Editor

SPECIAL REPORT

SERIALIZATION

CALIFORNIA 2015 & BEYOND

Sign up to receive timely updates from our editors and download this special report by Editor Jim Butschli.
 
Article tools:
|
Bookmark and Share

Mexico leads Latin America in pharmaceutical packaging

Pharmaceutical innovation and development represents an important aspect of the Latin American economy, with sales of US$24 billion in 2005, up 18.5-percent from 2004.

Mexico, Brazil, and Argentina are the three largest markets in the region, and were responsible for more than 80-percent of the region's sales in 2005. That's according to InfoAmericas, a conductor of research and business intelligence across Latin America and the Caribbean. In 2005, the combined annual growth rate of the top seven markets in the region reached 7-percent.

Mexico accounted for 37-percent of all pharmaceutical sales in the region, a 13-percent increase in 2005. Gains are mainly due to the country's growing economy, as well as the government's recent moves to expand healthcare. In 2005, domestic production amounted to nearly US$8 billion, representing about 1-percent of GDP for that year. Annual growth in Mexico is expected to remain at 12-percent through 2010, fueled by the overall economy and the expiration of more than 5,000 pharmaceutical patents. Multinational manufacturers are increasingly eyeing this attractive and growing market.

In such a dynamic market, industries such as pharmaceutical packaging play a decisive role. Packaging is an essential part of the pharmaceutical industry, and shapes the way medications are distributed, transported, displayed, and sold to consumers.

Several factors come into play when determining what type of package will be used for a given medication. The most visible one is consumer marketing. Especially with over-the-counter medications, companies aim to manufacture packaging materials that appeal to customers. The may incorporate logos, types, and colors that portray a serious, professional, and trustworthy image. Companies also package their medications conducive to their target market, for example, for seniors or children.

Another important factor is cost control. Some packaging materials offer superior barriers to the environment, but at a higher cost. The decisive factor is the medication's characteristics. Medications have different characteristics based on their active ingredients, which determine the degree to which a substance has to be protected from, say, moisture or light.

Packaging types can be divided into three broad categories: glass packaging, plastic bottles and flexible packaging. Flexible packaging can further divide into sachets, blisters, pouches and laminated tubes. Many flexible packaging types are also used for medical devices such as catheters, needles, surgical tools, and gauze.

The pharmaceutical packaging market in Mexico in 2006 was valued at US$27 million. Flexible packaging accounted for 58-percent, plastic bottles made up about 35-percent and glass packaging 7-percent. There are some medications that require a glass container due to the solution's characteristics. Blisters and other flexible packaging types have increased significantly as the leading packaging choice. These products are available in different sizes, colors, and characteristics that provide different permeability against moisture, dust, and light. A blister can be manufactured from a combination of PVC and aluminum in order to increase protection from sunlight. For other needs, the material mix might include HDPE, aluminum, and paper.

New developments in medication presentations, such as chewing gum and chewable medications, are increasingly popular because of the ease of ingesting the active ingredient. These medications are invariably packaged in blisters or plastic bottles due to their characteristics, highlighting the increased popularity of these two types of packaging.

Production regulations and requirements are a further factor to take into account. A country's health ministry or secretariat is in charge of regulating and supervising drug manufacturing through a series of laws and regulations. More often than not, companies choose to outsource their production due to the high costs associated with certification. Furthermore, if a given company only produces one medication, it would be unprofitable to build an entire facility for the production of one specialized drug. ...Read more

Liked this article? Start your subscription to Healthcare Packaging for FREE:

Sign up to receive the print magazine six times per year and the e-mail newsletter twice a month.

First Name:
Last Name:
 
Company:
Email Address:

 

* indicates a sponsored article that was submitted directly to this Web site by the supplier, and was not handled by the Healthcare Packaging editorial staff. Healthcare Packaging may share your contact information with our sponsors, as detailed in our Privacy Policy. Healthcare Packaging will not share your information with a sponsor whose content you have not reviewed.







Newsletters

Don’t miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
HEALTHCARE
PACKAGING MACHINERY

On the Edge

Keith Campbell speaks out!

New Machines

New packaging machines

FROM SISTER PUBLICATION AUTOMATION WORLD

Process Automation

Industry Trends & Applications

GENERAL INTEREST

eClip

Breaking packaging news

Packaging Insights

Pertinent packaging issues

PACKAGE DESIGN/
DEVELOPMENT

Greener Package

Sustainable packaging

Shelf Impact

Package design strategies

PACK EXPO
Each newsletter ranges in frequency from once per month to a few times per month at most.
Email: